Literature DB >> 24385376

Large streamlined trials in cardiovascular disease.

Gonzalo Calvo1, John J V McMurray, Christopher B Granger, Ángeles Alonso-García, Paul Armstrong, Marcus Flather, Antonio Gómez-Outes, Stuart Pocock, Norman Stockbridge, Anders Svensson, Frans Van de Werf.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24385376     DOI： 10.1093/eurheartj/eht535

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  9 in total

1.  Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

Authors:  Robert W Yeh; Matthew J Czarny; Sharon-Lise T Normand; Dean J Kereiakes; David R Holmes; Ralph G Brindis; W Douglas Weaver; John S Rumsfeld; Matthew T Roe; Sunghee Kim; Priscilla Driscoll-Shempp; Laura Mauri
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-16

2.  Perspective: Limiting Dependence on Nonrandomized Studies and Improving Randomized Trials in Human Nutrition Research: Why and How.

Authors:  John F Trepanowski; John P A Ioannidis
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

3.  Improving public health by improving clinical trial guidelines and their application.

Authors:  Martin J Landray; Jeroen J Bax; Laurence Alliot; Marc Buyse; Adam Cohen; Rory Collins; Gerhard Hindricks; Stefan K James; Sile Lane; Aldo P Maggioni; Ann Meeker-O'Connell; Gunnar Olsson; Stuart J Pocock; Michael Rawlins; Jonathan Sellors; Kaori Shinagawa; Karin R Sipido; Liam Smeeth; Richard Stephens; Murray W Stewart; Wendy Gattis Stough; Fergus Sweeney; Frans Van de Werf; Kerrie Woods; Barbara Casadei
Journal:  Eur Heart J       Date:  2017-06-01       Impact factor: 29.983

4.  Warning About Shortcuts in Drug Development.

Authors:  Robert M Califf
Journal:  J Am Heart Assoc       Date:  2017-03-21       Impact factor: 5.501

5.  Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.

Authors:  Kevin J Anstrom; Imre Noth; Kevin R Flaherty; Rex H Edwards; Joan Albright; Amanda Baucom; Maria Brooks; Allan B Clark; Emily S Clausen; Michael T Durheim; Dong-Yun Kim; Jerry Kirchner; Justin M Oldham; Laurie D Snyder; Andrew M Wilson; Stephen R Wisniewski; Eric Yow; Fernando J Martinez
Journal:  Respir Res       Date:  2020-03-12

6.  Overcoming challenges to data quality in the ASPREE clinical trial.

Authors:  Jessica E Lockery; Taya A Collyer; Christopher M Reid; Michael E Ernst; David Gilbertson; Nino Hay; Brenda Kirpach; John J McNeil; Mark R Nelson; Suzanne G Orchard; Kunnapoj Pruksawongsin; Raj C Shah; Rory Wolfe; Robyn L Woods
Journal:  Trials       Date:  2019-12-09       Impact factor: 2.279

7.  How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies.

Authors:  Arun Krishnamoorthy; Eric D Peterson; J David Knight; Kevin J Anstrom; Mark B Effron; Marjorie E Zettler; Linda Davidson-Ray; Brian A Baker; Patrick L McCollam; Daniel B Mark; Tracy Y Wang
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

8.  Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis.

Authors:  Mary Farrant; J Donald Easton; Eric E Adelman; Brett L Cucchiara; William G Barsan; Holly J Tillman; Jordan J Elm; Anthony S Kim; Anne S Lindblad; Yuko Y Palesch; Wenle Zhao; Keith Pauls; Kyle B Walsh; Joan Martí-Fàbregas; Richard A Bernstein; S Claiborne Johnston
Journal:  JAMA Netw Open       Date:  2019-09-04

Review 9.  Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study.

Authors:  Marion M Mafham; Louise J Bowman; Richard J Haynes; Jane M Armitage
Journal:  Diabetologia       Date:  2019-11-30       Impact factor: 10.122
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.